Cohort Study to Explore the Therapeutic Effect of Lenvatinib on Differentiated Thyroid Cancer

Trial Profile

Cohort Study to Explore the Therapeutic Effect of Lenvatinib on Differentiated Thyroid Cancer

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Lenvatinib (Primary)
  • Indications Thyroid cancer
  • Focus Therapeutic Use
  • Acronyms COLLECT
  • Most Recent Events

    • 01 Jul 2016 Status changed from not yet recruiting to recruiting.
    • 03 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top